OBJECTIVE: To study the concurrent validity of the Brazilian Composite International Diagnostic Interview 2.1 using as gold standard the clinical diagnoses based on the ICD-10 criteria and the Longitudinal, Expert, All Data (LEAD) procedure. METHOD: The sample was composed of 185 subjects selected at psychiatric hospitals, psychiatric outpatient units, the community, and primary care services. These individuals were intentionally selected according to 9 diagnostic groups. INSTRUMENTS: Composite International Diagnostic Interview (CIDI-core) version 2.1 (paper-and-pencil) administered by 16 trained interviewers. ANALYSIS: concurrent validity of diagnoses of the Composite International Diagnostic Interview 12-month. RESULTS: Values found for sensitivity and specificity in each diagnosis were: alcohol-related disorders (79.5%/97.2%); psychoactive substance-related disorders (77.3%/100%); schizophrenia and other psychotic disorders (28.6%/93.9%); manic episode and bipolar affective disorder (38.9%/96.4%); depressive disorder (82.5%/ 93.8%); phobic-anxiety disorder (80.6%/93.5%); obsessive-compulsive disorder (18.2%/98.9%); somatoform disorder (41.7%/90.8%); eating disorder (45.5%/100.0%). CONCLUSION: The Composite International Diagnostic Interview proved to be valid for diagnoses of alcohol-related disorders, psychoactive substance-related disorders, depressive disorder and phobic-anxiety disorder. The probable explanations for the poor performance for the other diagnoses were: necessity of some clinical judgement by the lay interviewer; difficulty to use the Probe Flow Chart; interviewees' difficulty of understanding; and lack of mechanisms to certify the veracity of the information.
OBJECTIVE: To study the concurrent validity of the Brazilian Composite International Diagnostic Interview 2.1 using as gold standard the clinical diagnoses based on the ICD-10 criteria and the Longitudinal, Expert, All Data (LEAD) procedure. METHOD: The sample was composed of 185 subjects selected at psychiatric hospitals, psychiatricoutpatient units, the community, and primary care services. These individuals were intentionally selected according to 9 diagnostic groups. INSTRUMENTS: Composite International Diagnostic Interview (CIDI-core) version 2.1 (paper-and-pencil) administered by 16 trained interviewers. ANALYSIS: concurrent validity of diagnoses of the Composite International Diagnostic Interview 12-month. RESULTS: Values found for sensitivity and specificity in each diagnosis were: alcohol-related disorders (79.5%/97.2%); psychoactive substance-related disorders (77.3%/100%); schizophrenia and other psychotic disorders (28.6%/93.9%); manic episode and bipolar affective disorder (38.9%/96.4%); depressive disorder (82.5%/ 93.8%); phobic-anxiety disorder (80.6%/93.5%); obsessive-compulsive disorder (18.2%/98.9%); somatoform disorder (41.7%/90.8%); eating disorder (45.5%/100.0%). CONCLUSION: The Composite International Diagnostic Interview proved to be valid for diagnoses of alcohol-related disorders, psychoactive substance-related disorders, depressive disorder and phobic-anxiety disorder. The probable explanations for the poor performance for the other diagnoses were: necessity of some clinical judgement by the lay interviewer; difficulty to use the Probe Flow Chart; interviewees' difficulty of understanding; and lack of mechanisms to certify the veracity of the information.
Authors: Sergio L Blay; Gerda G Fillenbaum; Marcelo F Mello; Maria I Quintana; Jair J Mari; Rodrigo A Bressan; Sergio B Andreoli Journal: J Affect Disord Date: 2018-02-17 Impact factor: 4.839
Authors: Gerda G Fillenbaum; Sergio L Blay; Marcelo F Mello; Maria I Quintana; Jair J Mari; Rodrigo A Bressan; Sergio B Andreoli Journal: J Affect Disord Date: 2019-03-05 Impact factor: 4.839
Authors: David A Pineda; Francisco Lopera; Isabel C Puerta; Natalia Trujillo-Orrego; Daniel C Aguirre-Acevedo; Liliana Hincapié-Henao; Clara P Arango; Maria T Acosta; Sandra I Holzinger; Juan David Palacio; Daniel E Pineda-Alvarez; Jorge I Velez; Ariel F Martinez; John E Lewis; Maximilian Muenke; Mauricio Arcos-Burgos Journal: Atten Defic Hyperact Disord Date: 2011-07-16
Authors: Maria Ines Quintana; Sergio Baxter Andreoli; Marcela Poctich Peluffo; Wagner Silva Ribeiro; Marcelo M Feijo; Rodrigo Affonseca Bressan; Evandro S F Coutinho; Jair de Jesus Mari Journal: PLoS One Date: 2015-08-07 Impact factor: 3.240
Authors: Maria Ines Quintana; Sergio B Andreoli; Fernanda G Moreira; Wagner S Ribeiro; Marcelo M Feijo; Rodrigo A Bressan; Evandro S F Coutinho; Jair J Mari Journal: PLoS One Date: 2013-05-14 Impact factor: 3.240
Authors: F G Moreira; M I Quintana; W Ribeiro; R A Bressan; M F Mello; J J Mari; S B Andreoli Journal: Biomed Res Int Date: 2015-04-27 Impact factor: 3.411
Authors: Sérgio Baxter Andreoli; Wagner Silva Ribeiro; Maria Ines Quintana; Camila Guindalini; Gerome Breen; Sergio Luis Blay; Evandro S F Coutinho; Trudy Harpham; Miguel Roberto Jorge; Diogo Rizzato Lara; Tais S Moriyama; Lucas C Quarantini; Ary Gadelha; Liliane Maria Pereira Vilete; Mary S L Yeh; Martin Prince; Ivan Figueira; Rodrigo A Bressan; Marcelo F Mello; Michael E Dewey; Cleusa P Ferri; Jair de Jesus Mari Journal: BMC Psychiatry Date: 2009-06-07 Impact factor: 3.630
Authors: Wagner Silva Ribeiro; Jair de Jesus Mari; Maria Inês Quintana; Michael E Dewey; Sara Evans-Lacko; Liliane Maria Pereira Vilete; Ivan Figueira; Rodrigo Affonseca Bressan; Marcelo Feijó de Mello; Martin Prince; Cleusa P Ferri; Evandro Silva Freire Coutinho; Sérgio Baxter Andreoli Journal: PLoS One Date: 2013-05-08 Impact factor: 3.240
Authors: Sergio Baxter Andreoli; Maíra Mendes Dos Santos; Maria Ines Quintana; Wagner Silva Ribeiro; Sergio Luiz Blay; Jose Geraldo Vernet Taborda; Jair de Jesus Mari Journal: PLoS One Date: 2014-02-14 Impact factor: 3.240